13F-HR filed by Opti Capital Management, LP
Opti Capital Management, LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 31 holding rows worth $585,292,000.
- Accession
- 0000919574-20-005249
- Filer
- CIK 1738654
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 31 entries on the cover page, a total value of $585,292,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $585,292,000 with VALUE read as thousands by filing date, 13F file number 028-19379. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TERADYNE INC | 880770AG7 | NOTE | 30,439 | $81,881,000 | thousands by filing date | principal |
| MANDIANT INC | 31816QAD3 | NOTE 1.625% 6/0 | 52,692 | $49,992,000 | thousands by filing date | principal |
| VERINT SYS INC | 92343XAA8 | NOTE 1.500% 6/0 | 47,193 | $47,080,000 | thousands by filing date | principal |
| NUTANIX INC | 67059NAB4 | NOTE 1/1 | 48,043 | $42,793,000 | thousands by filing date | principal |
| SUPERNUS PHARMACEUTICALS | 868459AD0 | BOND | 41,828 | $37,385,000 | thousands by filing date | principal |
| 8X8 INC NEW | 282914AB6 | BOND | 35,950 | $32,512,000 | thousands by filing date | principal |
| CYTOKINETICS INC | 23282WAA8 | NOTE 4.000%11/1 | 12,500 | $29,670,000 | thousands by filing date | principal |
| JAZZ INVESTMENTS I LTD | 472145AD3 | NOTE 1.500% 8/1 | 31,009 | $28,516,000 | thousands by filing date | principal |
| SYNAPTICS INC | 87157DAD1 | NOTE 0.500% 6/1 | 26,500 | $28,311,000 | thousands by filing date | principal |
| VISHAY INTERTECHNOLOGY INC | 928298AP3 | NOTE 2.250% 6/1 | 25,600 | $24,005,000 | thousands by filing date | principal |
| WAYFAIR INC | 94419LAD3 | NOTE 1.125%11/0 | 12,125 | $21,746,000 | thousands by filing date | principal |
| NEUROCRINE BIOSCIENCES INC | 64125CAD1 | NOTE 2.250% 5/1 | 9,000 | $14,988,000 | thousands by filing date | principal |
| NEW RELIC INC | 64829BAB6 | NOTE 0.500% 5/0 | 13,215 | $12,885,000 | thousands by filing date | principal |
| PTC THERAPEUTICS INC | 69366JAB7 | NOTE | 10,000 | $11,641,000 | thousands by filing date | principal |
| RAPID7 INC | 753422AB0 | NOTE | 8,500 | $11,470,000 | thousands by filing date | principal |
| Omeros Corp | 682143AE2 | NOTE 6.250%11/1 | 10,000 | $10,346,000 | thousands by filing date | principal |
| PACIRA BIOSCIENCES | 695127AD2 | NOTE 2.375% 4/0 | 8,545 | $9,370,000 | thousands by filing date | principal |
| INFINERA CORP | 45667GAC7 | BOND | 10,500 | $9,247,000 | thousands by filing date | principal |
| TWITTER INC | 90184LAD4 | NOTE 1.000% 9/1 | 8,092 | $7,945,000 | thousands by filing date | principal |
| WIX COM LTD | 92940WAB5 | NOTE 7/0 | 4,218 | $7,830,000 | thousands by filing date | principal |
| LIGAND PHARMACEUTICALS INC | 53220KAF5 | NOTE 0.750% 5/1 | 8,500 | $7,400,000 | thousands by filing date | principal |
| RAMBUS INC DEL | 750917AG1 | NOTE 1.375% 2/0 | 7,000 | $7,284,000 | thousands by filing date | principal |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 7,973 | $6,653,000 | thousands by filing date | principal |
| PLURALSIGHT INC | 72941BAB2 | NOTE 0.375% 3/0 | 7,500 | $6,626,000 | thousands by filing date | principal |
| OPKO HEALTH INC | 68375NAD5 | NOTE 4.500% 2/1 | 5,908 | $6,143,000 | thousands by filing date | principal |
| REDFIN CORP | 75737FAA6 | NOTE 1.750% 7/1 | 4,000 | $5,946,000 | thousands by filing date | principal |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 6,000 | $5,861,000 | thousands by filing date | principal |
| II VI INC | 902104AB4 | NOTE 0.250% 9/0 | 4,843 | $5,781,000 | thousands by filing date | principal |
| NEOGENOMICS INC | 64049MAA8 | Convertible Debt | 5,000 | $5,430,000 | thousands by filing date | principal |
| THERAVANCE INC | 88338TAB0 | CORPORATE OBLIG | 5,200 | $5,158,000 | thousands by filing date | principal |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 4,500 | $3,397,000 | thousands by filing date | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-20-005249 | this filing | 2020-08-14 | acceptance time not in the bulk data set |